UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma

International journal of molecular sciences, 2016-02, Vol.17 (3), p.280-280

2016

Volltextzugriff (PDF)

Road to elimination of HCV: Clinical challenges in HCV management

Liver international, 2022-08, Vol.42 (9), p.1935-1944

2022

Volltextzugriff (PDF)

Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients

Hepatology research, 2020-11, Vol.50 (11), p.1222-1233

2020

Volltextzugriff (PDF)

Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice

Scientific reports, 2024-02, Vol.14 (1), p.3362-3362, Article 3362

2024

Volltextzugriff (PDF)

Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL

The Journal of infectious diseases, 2023-03, Vol.227 (5), p.686-695

2023

Volltextzugriff (PDF)

Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice

Journal of gastroenterology, 2013-11, Vol.48 (11), p.1259-1270

2013

Volltextzugriff (PDF)

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

Journal of gastroenterology, 2019-03, Vol.54 (3), p.291-296

2019

Volltextzugriff (PDF)

Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection

Viruses, 2018-09, Vol.10 (10), p.531

2018

Volltextzugriff (PDF)

Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice

The American journal of pathology, 2015-05, Vol.185 (5), p.1275-1285

2015

Volltextzugriff (PDF)

Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines

Journal of gastroenterology, 2013-01, Vol.48 (1), p.1-12

2013

Volltextzugriff (PDF)

Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy

Journal of medical virology, 2015-11, Vol.87 (11), p.1913-1920

2015

Volltextzugriff (PDF)

Regression of Idiopathic Thrombocytopenic Purpura in a Patient With Eradication of Hepatitis C Virus by Direct‐Acting Antivirals

Hepatology (Baltimore, Md.), 2020-01, Vol.71 (1), p.389-391

2020

Volltextzugriff (PDF)

Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

Hepatology research, 2016-07, Vol.46 (8), p.758-764

2016

Volltextzugriff (PDF)

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.84-93

2011

Volltextzugriff (PDF)

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

Journal of hepatology, 2011-06, Vol.54 (6), p.1094-1101

2011

Volltextzugriff (PDF)

Genetics of IL28B and HCV--response to infection and treatment

Nature reviews. Gastroenterology & hepatology, 2012-07, Vol.9 (7), p.406-417

2012

Volltextzugriff (PDF)

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

Journal of gastroenterology, 2013-10, Vol.48 (10), p.1188-1204

2013

Volltextzugriff (PDF)

ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients

Gastroenterology (New York, N.Y. 1943), 2010-10, Vol.139 (4), p.1190-1197.e3

2010

Volltextzugriff (PDF)

Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure

Journal of gastroenterology and hepatology, 2023-09, Vol.38 (9), p.1637-1646

2023

Volltextzugriff (PDF)

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Viruses, 2015-10, Vol.7 (10), p.5328-5342

2015

Volltextzugriff (PDF)

Hepatitis C virus: How genetic variability affects pathobiology of disease

Journal of gastroenterology and hepatology, 2011-01, Vol.26 (s1), p.83-95

2011

Volltextzugriff (PDF)

Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP

Scientific reports, 2019-06, Vol.9 (1), p.8462, Article 8462

2019

Volltextzugriff (PDF)

Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay

PloS one, 2015-06, Vol.10 (6), p.e0130022-e0130022

2015

Volltextzugriff (PDF)

Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

Journal of viral hepatitis, 2021-09, Vol.28 (9), p.1304-1311

2021

Volltextzugriff (PDF)

1 – 25 von 533

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(483)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(532)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma

Road to elimination of HCV: Clinical challenges in HCV management

Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients

Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice

Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL

Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection

Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice

Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines

Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy

Regression of Idiopathic Thrombocytopenic Purpura in a Patient With Eradication of Hepatitis C Virus by Direct‐Acting Antivirals

Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

Genetics of IL28B and HCV--response to infection and treatment

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients

Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Hepatitis C virus: How genetic variability affects pathobiology of disease

Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP

Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay

Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

Suchergebnisse filtern